Literature DB >> 26099834

Why screening for type 2 diabetes is necessary even in poor resource settings.

Ranjit Unnikrishnan1, Viswanathan Mohan2.   

Abstract

Screening for type 2 diabetes (T2DM) remains controversial, in spite of the explosive increase in the prevalence of the disorder and the morbidity and mortality associated with its complications. In this review, we attempt to show that T2DM is an ideal candidate disease for screening, and why screening is needed to improve clinical outcomes and prevent complications. We also suggest that screening can be made more cost-effective by adopting a targeted approach and utilizing low-cost tools. We conclude that screening for T2DM is warranted even in resource-constrained settings, and provide examples from rural India showing that such an approach is feasible with meticulous planning and judicious allocation of resources.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complications; Cost-effective; Resource constrained settings; Screening; Type 2 diabetes

Mesh:

Year:  2015        PMID: 26099834     DOI: 10.1016/j.jdiacomp.2015.05.011

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  3 in total

1.  Comparison between New-Onset and Old-Diagnosed Type 2 Diabetes with Ketosis in Rural Regions of China.

Authors:  Shichun Du; Xia Yang; Degang Shi; Qing Su
Journal:  Int J Endocrinol       Date:  2016-02-04       Impact factor: 3.257

2.  Diabetes Screening and Prevention in a High-Risk, Medically Isolated Border Community.

Authors:  Ann V Millard; Margaret A Graham; Nelda Mier; Jesus Moralez; Maria Perez-Patron; Brian Wickwire; Marlynn L May; Marcia G Ory
Journal:  Front Public Health       Date:  2017-06-12

3.  Economic evaluation of population-based type 2 diabetes mellitus screening at different healthcare settings in Vietnam.

Authors:  Phung Lam Toi; Olivia Wu; Montarat Thavorncharoensap; Varalak Srinonprasert; Thunyarat Anothaisintawee; Ammarin Thakkinstian; Nguyen Khanh Phuong; Usa Chaikledkaew
Journal:  PLoS One       Date:  2021-12-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.